NL-OMON47401
Recruiting
Not Applicable
Validation of Pharmacokinetic and Pharmacodynamic Assays for determination of Nivolumab and Pembrolizumab concentrations, and the occupancy of their target receptor Programmed Death-1 (PD-1) on T-cells - Developing Assays for Anti-PD-1 monoclonal antibodies
Antoni van Leeuwenhoek Ziekenhuis0 sites70 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- metastasized cancer
- Sponsor
- Antoni van Leeuwenhoek Ziekenhuis
- Enrollment
- 70
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with solid tumors who will start treatment with nivolumab or pembrolizumab and are willing to undergo blood sampling and/or donate residual material.
Exclusion Criteria
- •Patients with known alcoholism, drug addiction, psychotic disorders in the history and/or other reasons, for which they are not amendable for adequate follow up.
- •Uncontrolled infectious disease or known HIV\-1 or HIV\-2 type patients.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. - NDbipolar disordersMedDRA version: 9.1Level: LLTClassification code 10057667Term: Bipolar disorderEUCTR2008-000370-20-ITAZIENDA OSPEDALIERA PISANA
Not yet recruiting
Not Applicable
Examining the pharmacokinetic and pharmacodynamic profile of biperidegeheugen/ memoryNL-OMON24672Maastricht University27
Recruiting
Not Applicable
Examining the pharmacokinetic and pharmacodynamic profile of biperideNL-OMON47428niversiteit Maastricht42
Not yet recruiting
Not Applicable
A study on the pharmacokinetics and pharmacodynamics of remimazolam during total intravenous anesthesia with remifentanilNot ApplicableKCT0007066Inje University Busan Paik Hospital15
Not yet recruiting
Not Applicable
A Clinical Trial for Evaluation of Pharmacokinetic interaction between WS1313D and NAC after Co-administration in Healthy Male Adult SubjectsDiseases of the nervous systemKCT0004878Woosung Pharma27